We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Zimmer Completes Offer for Centerpulse

By HospiMedica staff writers
Posted on 15 Oct 2003
Stating that it is now the leading "pure-play” orthopedics company in the world, Zimmer Holdings, Inc. More...
(Warsaw, IN, USA) has announced the closing of its offer for Centerpulse AG (Zurich, Switzerland).

As a result of the exchange offer, Zimmer now owns 98.7% of the issued Centerpulse shares and 99.9% of the issued shares held by InCentive Capital AG, which owned 18.3% of Centerpulse shares. Zimmer intends to promptly initiate the process to acquire all of the shares that remain outstanding, thereby concluding an offer that began in May 2003 when the company first announced its offer of around US$3.1 billion for Centerpulse.

The transaction creates a company with combined 2002 sales of more than $2 billion; more than 100,000 products in the reconstructive, trauma, spine, dental, and orthopedic surgery areas; and more than 1,000 patents. Zimmer estimates that about 25% of its sales will be generated in Europe. The addition of Centerpulse bolsters Zimmer's presence in Europe, while complementing its market strengths in the USA and the Japan/Asia Pacific regions.

"This strategic transaction solidifies our industry leadership and creates a powerful engine for future growth with exceptional research and development capabilities; a dedicated and culturally diverse work force; and venders, partners, and sales representatives worthy of envy. Patient quality of life and a passion to win will continue to guide us,” said Ray Elliot, chairman, president, and CEO of Zimmer.





Related Links:
Zimmer
Centerpulse

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Morcellator
TCM 3000 BL
Medical Monitor
SILENIO D
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.